Company · France · EU Transparency Register 985424099268-34
Counts here are a floor, never a total: they cover the 665 consultation files tracked so far (57,774 submissions, mostly 2021–26), so an organization's real filing history is larger, not smaller.
Among the 1210 companies & groups on this site, they rank #507 by legislative files engaged, a count of participation, not a measure of influence.
Self-declared to the EU Transparency Register (snapshot 14 Oct 2026).
Self-declared to the EU Transparency Register (snapshot 14 Oct 2026); cost bands are floors, not audited totals. Reused under Commission Decision 2011/833/EU.
Track laboratoire in PolicySpeak: request access →
Work at laboratoire Astelia? so we know who speaks for it.
laboratoire Astelia filed 3 positions between 1 Dec 2025 and 12 May 2026, across 3 of the 665 legislative files tracked here, attaching a full position paper 1 time.
This draft act is of major importance for the biocidal products sector. We welcome the fact that the scope of ecodesign requirements also covers products contributing to the protection of the health of the general public, in particular products falling under type TP19 of the biocidal regulation.
Filed in French · English published by the European Commission
Regulation (EU) No 528/2012 (BPR) constitutes a necessary and valuable framework to monitor active substances and biocidal formulations placed on the European market. It ensures a high level of protection for human health and the environment and provides a harmonized system of evaluation across Member States. Biocides are, in many cases, the only available tools for protection against vector-borne diseases.
Opening of the attached position paper · the full paper is on the Commission’s record (source link above)
The proposed amendments affecting biocidal products, in particular the inclusion of the Committee for Socio-economic Analysis (SEAC) in the evaluation processes and the structural simplification of the text, are conducive to more consistent regulation capable of taking into account the real health impact of biocides on the population.
Filed in French · English published by the European Commission
Looking for an argument rather than an organization? Search every submission for a phrase and see everyone who used it.
Put laboratoire Astelia next to another organization. Same files, same register facts, side by side. Compare →
Organizations that also filed on at least two of the same consultations. A shared interest in the same dossiers, not evidence of coordination, and we do not suggest any.
Showing 5 of 16.
Everything on this page comes from laboratoire Astelia’s own submissions to the European Commission. We have added nothing and interpreted nothing. If something is wrong or out of date, email info@policyspeak.com and we will correct it. If you are an individual named in a record, our privacy policy sets out your rights to correction, objection and removal.
Quotes are verbatim from submissions published by the European Commission, trimmed to their opening passage and never summarized by a model. Organizations only, never individuals. Reused under Commission Decision 2011/833/EU; the European Commission is not liable for this reuse.